5 型磷酸二酯酶抑制剂加内皮素受体拮抗剂治疗第 1 组肺动脉高压与单用其中一种相比

{"title":"5 型磷酸二酯酶抑制剂加内皮素受体拮抗剂治疗第 1 组肺动脉高压与单用其中一种相比","authors":"Yuji Oba, Yohannes Goite, T. Maduke, Eddie W. Fakhouri","doi":"10.1002/14651858.cd015824","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502632,"journal":{"name":"Cochrane Database of Systematic Reviews","volume":"80 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension\",\"authors\":\"Yuji Oba, Yohannes Goite, T. Maduke, Eddie W. Fakhouri\",\"doi\":\"10.1002/14651858.cd015824\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":502632,\"journal\":{\"name\":\"Cochrane Database of Systematic Reviews\",\"volume\":\"80 17\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cochrane Database of Systematic Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/14651858.cd015824\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cochrane Database of Systematic Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/14651858.cd015824","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}